Haleon plc (HLNCF)
OTCMKTS · Delayed Price · Currency is USD
4.635
+0.045 (0.98%)
Oct 31, 2025, 4:00 PM EDT
Haleon Market Cap
Haleon has a market cap or net worth of $41.42 billion as of October 31, 2025. Its market cap has decreased by -6.87% in one year.
Market Cap
41.42B
Enterprise Value
51.83B
Revenue
15.10B
Ranking
n/a
PE Ratio
19.86
Stock Price
$4.64
Market Cap Chart
Since July 18, 2022, Haleon's market cap has increased from 34.14B to 41.42B, an increase of 21.31%. That is a compound annual growth rate of 6.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 41.42B | -3.16% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 655.38M |
| Glass House Brands | 563.30M |
| Northwest Biotherapeutics | 366.55M |
| Silence Therapeutics | 345.28M |
| Nika Pharmaceuticals | 312.10M |
| CytoDyn | 302.34M |
| American Oncology Network | 297.14M |